Eli Lilly

Healthcare

Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments

Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom

The company also said earlier this week it will drop $6 billion on a new manufacturing facility in Huntsville, Alabama.

2 min read

Photo via Cfoto/ZUMAPRESS/Newscom

Healthcare

CEO Says AstraZeneca Can ‘Absorb’ Costs of Trump-Driven US Deals

AstraZeneca is the biggest drugmaker in Britain and its £193 billion ($253 billion) market capitalization tops the London Stock Exchange.

2 min read
Photo via Mads Claus Rasmussen/ZUMAPRESS/Newscom

M&A

Novo Nordisk’s $10 Billion Bid Ups the Ante in Bidding War for Obesity Biotech Metsera

Metsera on Tuesday called Novo Nordisk’s new $10 billion offer “superior” to rival Pfizer’s bid of $8 billion.

2 min read
Photo by Douglas Cliff via iStock

Healthcare

Eli Lilly’s Sterling Results Highlight Rival Novo Nordisk’s Fading Fortunes

Record performance of its GLP-1 drugs sent shares in Eli Lilly soaring almost 4% after its earnings call on Thursday.

2 min read

Healthcare

Novo Nordisk Seeks to Expand Liver Disease Treatments in $5.2B Deal for Bay Area Biotech

Photo via Ritzau Scanpix/Sipa USA/Newscom

The acquisition comes as new CEO Mike Doustdar tries to revive once meteoric growth that has come crashing down to earth this year.

2 min read

Healthcare

Lung Disease Breakthrough Boosts United Therapeutics — and its Rivals

Photo by Robina Weermeijer via Unsplash

About 5 million people are affected by idiopathic pulmonary fibrosis globally, according to the National Institutes of Health.

2 min read

Healthcare

Novo Nordisk Backs Away From Hims & Hers Partnership

Photo via Abaca Press/Blondet Eliot/Abaca/Sipa USA/Newscom

Novo and Hims’ April team-up turned the two firms from competitors into collaborators at just the right moment.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.